A carregar...
A better prediction of progression‐free survival in diffuse large B‐cell lymphoma by a prognostic model consisting of baseline TLG and %ΔSUV(max)
In the era of rituximab, the International Prognostic Index (IPI) has been inefficient in initial risk stratification for patients with R‐CHOP‐treated diffuse large B‐cell lymphoma (DLBCL). To estimate the predictive values of PET/CT quantitative parameters and three prognostic models consisting of...
Na minha lista:
| Publicado no: | Cancer Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6718622/ https://ncbi.nlm.nih.gov/pubmed/31343111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2284 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|